NOVOSEVEN Side Effects

7009315-4 | Shock Haemorrhagic
on Sep 16, 2010 Male patient from JAPAN , 54 years of age, weighting 213.8 lb, was diagnosed with acquired haemophilia and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: shock haemorrhagic. Novoseven dosage: 20 Mg, Unk. During the same period patient was treated with RABEPRAZOLE SODIUM (10 Mg, Qd) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), PREDNISOLONE (10 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), MAGNESIUM OXIDE (1800 Mg, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), WHOLE BLOOD (8 Units) (View Whole Blood Review and Whole Blood Label ).

6966925-8 | Embolism Arterial
Patient was taking Novoseven (View Usage). Patient had the following side effects: embolism arterial on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 6.61 lb, was diagnosed with post procedural haemorrhage and. Novoseven dosage: 70 Cg/kg/90 Min Apart. During the same period patient was treated with BLOOD CELLS, PACKED HUMAN (View Blood Cells, Packed Human Review and Blood Cells, Packed Human Label ), PLATELETS (View Platelets Review and Platelets Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), CRYOPRECIPITATES (View Cryoprecipitates Review and Cryoprecipitates Label ).

6942311-1 | Disseminated Intravascular Coagulation, Organ Failure
Adverse event was reported on Aug 18, 2010 by a Female patient taking Novoseven (View Usage) (Dosage: ) was diagnosed with haemorrhage and. Location: AUSTRALIA , 70 years of age, After Novoseven was administered, patient had the following side effects: disseminated intravascular coagulation, organ failure. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6936167-0 | Candida Sepsis
on Aug 12, 2010 Male patient from FRANCE , child 10 years of age, was diagnosed with haemophilia and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: candida sepsis. Novoseven dosage: 133.3 Ug/kg, Unk. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ). Patient was hospitalized.


6936099-8 | Candida Sepsis
on Aug 12, 2010 Male patient from FRANCE , child 10 years of age, weighting 61.73 lb, was diagnosed with prophylaxis, haemophilia and was treated with Novoseven (View Usage). Patient had the following side effects: candida sepsis. Novoseven dosage: 133.3 Ug/kg, Unk. Patient was hospitalized.

6907668-6 | Shock Haemorrhagic
Patient was taking Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: shock haemorrhagic on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, weighting 172.0 lb, was diagnosed with retroperitoneal haemorrhage and. Novoseven dosage: Every 3 Hours. During the same period patient was treated with METHYLPREDNISOLONE (500 Mg, Qd) (View Methylprednisolone Review and Methylprednisolone Label ), HUMAN RED BLOOD CELLS (4 U, Qd) (View Human Red Blood Cells Review and Human Red Blood Cells Label ), TAKEPRON (15 Mg, Qd) (View Takepron Review and Takepron Label ).

6899943-9 | Haemorrhage, Shock Haemorrhagic
Adverse event was reported on Oct 23, 2006 by a Female patient taking Novoseven (View Usage) (Dosage: 4.8 Mg X 34 In Total) was diagnosed with haemorrhage and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhage, shock haemorrhagic. During the same period patient was treated with LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), GASTER D (20 Mg, Qd) (View Gaster D Review and Gaster D Label ), PANSPORIN (2 G, Qd) (View Pansporin Review and Pansporin Label ), NEOPHYLLIN /00003701/ (250 Mg, Qd) (View Neophyllin /00003701/ Review and Neophyllin /00003701/ Label ), OMEPRAL /00661202/ (20 Mg, Qd) (View Omepral /00661202/ Review and Omepral /00661202/ Label ), PREDNISOLON /00016201/ (40 Mg, Qd) (View Prednisolon /00016201/ Review and Prednisolon /00016201/ Label ), RED BLOOD CELLS (2-4 U) (View Red Blood Cells Review and Red Blood Cells Label ).

6839752-X | Candida Sepsis
on Jul 07, 2010 Male patient from FRANCE , child 10 years of age, was diagnosed with haemophilia and was treated with Novoseven (View Usage). Patient had the following side effects: candida sepsis. Novoseven dosage: 3.6 Mg/48h/iv. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ). Patient was hospitalized.

6823254-0 | Cardiac Failure
on Jul 01, 2010 Male patient from COSTA RICA , 25 years of age, was diagnosed with surgery (What is surgery?) and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: cardiac failure. Novoseven dosage: 9 Pieces.

6812182-2 | Cardiac Arrest
Patient was taking Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?) on Jun 25, 2010 from ARGENTINA Additional patient health information: Female patient , 34 years of age, was diagnosed with haemorrhage and. Novoseven dosage: 1.2 Mg, Unk.

6809752-4 |
Adverse event was reported on Jun 23, 2010 by a Male patient taking Novoseven (View Usage) (Dosage: 4.8 Mg, Unk) was diagnosed with international normalised ratio increased and. Location: ISRAEL , 37 years of age, .

6794694-3 | Cardiac Failure
on Jun 16, 2010 Male patient from COSTA RICA , 25 years of age, was diagnosed with surgery (What is surgery?) and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: cardiac failure. Novoseven dosage: 9 Pieces.

6790129-5 | Concomitant Disease Progression
on Jun 16, 2010 Male patient from ISRAEL , 18 years of age, was diagnosed with haemorrhage and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease progression. Novoseven dosage: 7.2 Mg, Qd.

6781329-9 | Blood Fibrinogen Increased, Deep Vein Thrombosis, Pyrexia, Septic Embolus, Thrombophlebitis Superficial
Patient was taking Novoseven (View Usage). Patient had the following side effects: blood fibrinogen increased, deep vein thrombosis (What is deep vein thrombosis?), pyrexia, septic embolus, thrombophlebitis superficial on Jun 09, 2010 from UNITED STATES Additional patient health information: Male patient , 31 years of age, weighting 169.8 lb, was diagnosed with haemophilia a with anti factor viii and. Novoseven dosage: Multiple Infusions. Patient was hospitalized.

6775125-6 | Disseminated Intravascular Coagulation
Adverse event was reported on Jun 09, 2010 by a Female patient taking Novoseven (View Usage) (Dosage: 4.8 Mg, Single) was diagnosed with operative haemorrhage and. Location: JAPAN , 70 years of age, weighting 105.8 lb, After Novoseven was administered, patient had the following side effects: disseminated intravascular coagulation.

6766767-2 | Disseminated Intravascular Coagulation, Haemorrhage Intracranial, Multi-organ Failure
on Jun 02, 2010 Male patient from KAZAKHSTAN , child 6 years of age, was diagnosed with haemophilia a with anti factor viii and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, haemorrhage intracranial, multi-organ failure. Novoseven dosage: 2.4 Mg, Unk. During the same period patient was treated with FEIBA /01034301/ (Unk) (View Feiba /01034301/ Review and Feiba /01034301/ Label ), FACTOR VIII (Unk) (View Factor Viii Review and Factor Viii Label ).

6745801-X | Haemothorax
on May 18, 2010 Male patient from THAILAND , child 9 years of age, was diagnosed with post procedural haemorrhage and was treated with Novoseven (View Usage). Patient had the following side effects: haemothorax. Novoseven dosage: Divided Into Nine Doses. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TRANSAMINE (View Transamine Review and Transamine Label ).

6745799-4 | Carotid Artery Occlusion, Cerebral Infarction
Patient was taking Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: carotid artery occlusion, cerebral infarction on May 18, 2010 from THAILAND Additional patient health information: Male patient , child 5 years of age, was diagnosed with post procedural haemorrhage and. Novoseven dosage: Divided Into 10 Doses. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TRANSAMINE (View Transamine Review and Transamine Label ).

6734017-9 | Meningitis Meningococcal, Sepsis
Adverse event was reported on May 10, 2010 by a Female patient taking Novoseven (View Usage) (Dosage: 3 Iu/kg/hour) was diagnosed with factor vii deficiency and. Location: ALGERIA , 21 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: meningitis meningococcal, sepsis (What is sepsis?).

6723600-2 | Atrial Thrombosis
on May 03, 2010 Male patient from SWITZERLAND , 58 years of age, weighting 187.4 lb, was diagnosed with haemorrhage and was treated with Novoseven (View Usage). Patient had the following side effects: atrial thrombosis. Novoseven dosage: 7.2 Mg Bolus. During the same period patient was treated with BERIPLEX (Unk) (View Beriplex Review and Beriplex Label ).

6709214-9 | Contusion, Pain
on Apr 19, 2010 Male patient from UNITED STATES , weighting 176.0 lb, was diagnosed with haemophilia b with anti factor ix and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: contusion, pain (What is pain?). Novoseven dosage: 240 Ug/kg, Single. Patient was hospitalized.

6703017-7 | Embolic Stroke, Post Procedural Stroke
Patient was taking Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: embolic stroke, post procedural stroke on Apr 29, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 130.1 lb, was diagnosed with post procedural haemorrhage and. Novoseven dosage: 5 Mg Once Iv. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6702611-7 | Contusion, Pain
Adverse event was reported on Apr 19, 2010 by a Male patient taking Novoseven (View Usage) (Dosage: 240 Ug/kg, Single) was diagnosed with haemophilia b with anti factor ix and. Location: UNITED STATES , weighting 176.0 lb, Patient had the following side effects: contusion, pain (What is pain?). Patient was hospitalized.

6653642-7 | Hypoxia
on Mar 17, 2010 Female patient from JAPAN , weighting 5.73 lb, was diagnosed with pleural haemorrhage and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: hypoxia. Novoseven dosage: 23 Mg, Qid. During the same period patient was treated with FIBRINASE (View Fibrinase Review and Fibrinase Label ), MENATETRENONE (6 Mg, Qd) (View Menatetrenone Review and Menatetrenone Label ), TRANSAMIN (/iv) (View Transamin Review and Transamin Label ), RED BLOOD CELLS (786.8ml/div) (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS (104.1ml/div) (View Platelets Review and Platelets Label ), PLASMA (35.8ml) (View Plasma Review and Plasma Label ).

6652912-6 | Concomitant Disease Progression
on Mar 16, 2010 Male patient from ISRAEL , 14 years of age, was diagnosed with haemorrhage and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease progression. Novoseven dosage: .

6636608-2 | Myocardial Infarction
Patient was taking Novoseven (View Usage). Patient had the following side effects: myocardial infarction on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with surgery (What is surgery?) and. Novoseven dosage: Intravenous. During the same period patient was treated with FEIBA (View Feiba Review and Feiba Label ).

6631741-3 |
Adverse event was reported on Mar 02, 2010 by a Female patient taking Novoseven (View Usage) (Dosage: 8.2 Mg, Unk) was diagnosed with haemorrhage and. Location: ISRAEL , 26 years of age, . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6631637-7 | Abdominal Pain, Flank Pain
on Mar 04, 2010 Male patient from UNITED STATES , weighting 174.2 lb, was diagnosed with factor viii deficiency and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), flank pain. Novoseven dosage: 4.8 Ug, Every 2 Hours. During the same period patient was treated with ALPHANATE (7000 Iu, Unk) (View Alphanate Review and Alphanate Label ), ALLOPURINOL (100 Mg, Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6617551-1 | Cerebrovascular Accident
on Feb 23, 2010 Male patient from ITALY , 72 years of age, was diagnosed with post procedural haemorrhage and was treated with Novoseven (View Usage). Patient had the following side effects: cerebrovascular accident. Novoseven dosage: 70 Ug/kg Single Dose. During the same period patient was treated with TRANEXAMIC ACID (10 Mg/kg, Qd) (View Tranexamic Acid Review and Tranexamic Acid Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6581081-6 |
Patient was taking Novoseven (View Usage). on Feb 04, 2010 from JAPAN Additional patient health information: Female patient , weighting 9.92 lb, was diagnosed with pleural haemorrhage and. Novoseven dosage: 0.4 Mg, Qd. During the same period patient was treated with TACHOCOMB /02406701/ (View Tachocomb /02406701/ Review and Tachocomb /02406701/ Label ), RED BLOOD CELLS (283.3ml/div) (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS (283.3ml/div) (View Platelets Review and Platelets Label ), FRESH FROZEN PLASMA (141.7ml/div) (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), TRANSAMIN (/iv) (View Transamin Review and Transamin Label ).

6581080-4 |
Adverse event was reported on Feb 04, 2010 by a Female patient taking Novoseven (View Usage) (Dosage: 0.84 Mg, X6) was diagnosed with pleural haemorrhage and. Location: JAPAN , weighting 19.84 lb, . During the same period patient was treated with RED BLOOD CELLS (591.7ml/div) (View Red Blood Cells Review and Red Blood Cells Label ), FRESH FROZEN PLASMA (513.3ml/div) (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), PLATELETS (137.5ml/div) (View Platelets Review and Platelets Label ).

6581079-8 |
on Feb 04, 2010 Female patient from JAPAN , weighting 77.16 lb, was diagnosed with pleural haemorrhage and was treated with Novoseven (View Usage). . Novoseven dosage: 3.6 Mg, Bid. During the same period patient was treated with INSULIN ASPART PROTAMINE (35 Mg, Qd) (View Insulin Aspart Protamine Review and Insulin Aspart Protamine Label ), RED BLOOD CELLS (12080 Ml, Unk) (View Red Blood Cells Review and Red Blood Cells Label ), FRESH FROZEN PLASMA (7140 Ml, Qd) (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), SODIUM CHLORIDE (2500 Ml, Qd) (View Sodium Chloride Review and Sodium Chloride Label ), BLOOD CELLS, PACKED HUMAN (1600 Ml, Qd) (View Blood Cells, Packed Human Review and Blood Cells, Packed Human Label ), TACHOCOMB /01721101/ (View Tachocomb /01721101/ Review and Tachocomb /01721101/ Label ).

6577497-4 | Hypoxia
on Feb 04, 2010 Female patient from JAPAN , weighting 5.73 lb, was diagnosed with pleural haemorrhage and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: hypoxia. Novoseven dosage: 23 Mg, Qid. During the same period patient was treated with FIBRINASE (View Fibrinase Review and Fibrinase Label ), MENATETRENONE (6 Mg, Qd) (View Menatetrenone Review and Menatetrenone Label ), TRANSAMIN (/iv) (View Transamin Review and Transamin Label ), RED BLOOD CELLS (786.8ml/div) (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS (104.1ml/div) (View Platelets Review and Platelets Label ), PLASMA (35.8ml) (View Plasma Review and Plasma Label ).

6550347-8 | Pulmonary Embolism
Patient was taking Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Jan 13, 2010 from GERMANY Additional patient health information: Male patient , 20 years of age, was diagnosed with injury and. Novoseven dosage: 9 Mg, Single.

6543892-2 | Compartment Syndrome, Disease Recurrence, Haemorrhage
Adverse event was reported on Jan 13, 2010 by a Male patient taking Novoseven (View Usage) (Dosage: 200 Ug/kg, Single) was diagnosed with haemophilia a with anti factor viii and. Location: ARGENTINA , child 11 years of age, weighting 50.71 lb, Patient had the following side effects: compartment syndrome, disease recurrence, haemorrhage.

6540749-8 | International Normalised Ratio Increased
on Jan 08, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with haemorrhage intracranial, stent placement and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: international normalised ratio increased. Novoseven dosage: 4.8 Mg, Single. During the same period patient was treated with COUMADIN (Unk) (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6534139-1 | Jugular Vein Thrombosis, Thrombosis In Device, Venous Thrombosis Limb
on Jan 04, 2010 Male patient from AUSTRALIA , 19 years of age, was diagnosed with haemorrhage, coagulopathy and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: jugular vein thrombosis, thrombosis in device, venous thrombosis limb. Novoseven dosage: 20 Ug/kg, Unk. During the same period patient was treated with RED BLOOD CELLS (6 U, Unk) (View Red Blood Cells Review and Red Blood Cells Label ), PLASMA (9 U, Unk) (View Plasma Review and Plasma Label ), PLATELETS (8 U, Unk) (View Platelets Review and Platelets Label ).

6531272-5 | Haemorrhage
Patient was taking Novoseven (View Usage). Patient had the following side effects: haemorrhage on Jan 04, 2010 from ISRAEL Additional patient health information: Female patient , 89 years of age, was diagnosed with haemorrhage and. Novoseven dosage: 8.4 Mg, Qd.

6530293-6 | Myocardial Infarction
Adverse event was reported on Dec 21, 2009 by a Male patient taking Novoseven (View Usage) (Dosage: 90 Ug/kg Repeated At 3 Hour Intervals X5) was diagnosed with gastrointestinal haemorrhage and. Location: UNITED KINGDOM , 73 years of age, After Novoseven was administered, patient had the following side effects: myocardial infarction.

6523553-6 | Multi-organ Failure
on Dec 25, 2009 Male patient from JAPAN , 70 years of age, weighting 132.3 lb, was diagnosed with haemostasis and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure. Novoseven dosage: 4.8mg X 2.

6517764-3 | Deep Vein Thrombosis, Pneumatosis Intestinalis
on Dec 14, 2009 Female patient from UNITED STATES , 49 years of age, was diagnosed with haemorrhage and was treated with Novoseven (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pneumatosis intestinalis. Novoseven dosage: Unk. Patient was hospitalized.

6507082-1 | Abdominal Pain, Flank Pain, Haematuria, Nausea, Thrombosis
Patient was taking Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), flank pain, haematuria, nausea (What is nausea?), thrombosis on Dec 10, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 174.2 lb, was diagnosed with factor viii deficiency and. Novoseven dosage: 4.8 Ug, Every 2 Hours. During the same period patient was treated with ALPHANATE (7000 Iu, Unk) (View Alphanate Review and Alphanate Label ), ALLOPURINOL (100 Mg, Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6504986-0 | Device Failure, Haemarthrosis, Postoperative Wound Infection, Therapeutic Response Decreased
Adverse event was reported on Dec 09, 2009 by a Male patient taking Novoseven (View Usage) (Dosage: 90 Ug/kg Bolus) was diagnosed with haemorrhage prophylaxis and. Location: UNITED KINGDOM , 51 years of age, weighting 157.6 lb, Patient experienced the following unwanted or unexpected effects: device failure, haemarthrosis, postoperative wound infection, therapeutic response decreased. During the same period patient was treated with FACTOR VIII (1 Bolus) (View Factor Viii Review and Factor Viii Label ).

6504985-9 | Device Related Sepsis, Operative Haemorrhage, Post Procedural Haemorrhage, Postoperative Wound Infection
on Dec 09, 2009 Male patient from UNITED KINGDOM , 41 years of age, weighting 141.3 lb, was diagnosed with haemorrhage prophylaxis and was treated with Novoseven (View Usage). Patient had the following side effects: device related sepsis, operative haemorrhage, post procedural haemorrhage, postoperative wound infection. Novoseven dosage: 90 Ug/kg Bolus.

6504984-7 | Postoperative Wound Infection
on Dec 09, 2009 Male patient from UNITED KINGDOM , 41 years of age, weighting 218.3 lb, was diagnosed with haemorrhage prophylaxis and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: postoperative wound infection. Novoseven dosage: 90 Ug/kg Bolus.

6504982-3 | Post Procedural Haemorrhage
Patient was taking Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural haemorrhage on Dec 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, weighting 172.0 lb, was diagnosed with haemorrhage prophylaxis and. Novoseven dosage: 90 Ug/kg Bolus.

6504981-1 | Extravasation, Infusion Site Thrombosis, Operative Haemorrhage, Postoperative Wound Infection
Adverse event was reported on Dec 09, 2009 by a Male patient taking Novoseven (View Usage) (Dosage: 90 Ug/kg Bolus) was diagnosed with haemorrhage prophylaxis and. Location: UNITED KINGDOM , 52 years of age, weighting 163.1 lb, Patient had the following side effects: extravasation, infusion site thrombosis, operative haemorrhage, postoperative wound infection. During the same period patient was treated with PLATELETS (View Platelets Review and Platelets Label ), CRYOPRECIPITATES (View Cryoprecipitates Review and Cryoprecipitates Label ).

6503674-4 | Anaemia, Haemarthrosis, Thrombocytopenia
on Dec 09, 2009 Male patient from UNITED KINGDOM , 25 years of age, weighting 132.3 lb, was diagnosed with haemostasis and was treated with Novoseven (View Usage). After Novoseven was administered, patient had the following side effects: anaemia, haemarthrosis, thrombocytopenia. Novoseven dosage: 90 Ug/kg, Single.

6489618-2 | Cardio-respiratory Arrest, Haemobilia, Hepatic Haemorrhage, Shock Haemorrhagic
on Dec 03, 2009 Male patient from JAPAN , 50 years of age, weighting 132.3 lb, was diagnosed with haemostasis and was treated with Novoseven (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, haemobilia, hepatic haemorrhage, shock haemorrhagic. Novoseven dosage: Every 3 Hours.

6477668-1 | Concomitant Disease Progression
Patient was taking Novoseven (View Usage). Patient had the following side effects: concomitant disease progression on Nov 25, 2009 from JAPAN Additional patient health information: Male patient , weighting 105.8 lb, was diagnosed with haemophilia a with anti factor viii and. Novoseven dosage: 4.8 Mg, Single.